# Paola Mina‐Osorio

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paola-mina-osorio/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,792 |
| Field | Dermatology and Skin Diseases |
| h-index | 22 |
| i10-index | 26 |
| Last Known Institution | Myovant Sciences (United States) |
| OpenAlex ID | https://openalex.org/A5090425493 |
| Works | 53 |

## Researcher papers

- [Atopic dermatitis in the pediatric population](https://scholariq.org/papers/atopic-dermatitis-in-the-pediatric-population/)
- [The atopic march and atopic multimorbidity: Many trajectories, many pathways](https://scholariq.org/papers/the-atopic-march-and-atopic-multimorbidity-many-trajectories-many-pathways/)
- [The moonlighting enzyme CD13: old and new functions to target](https://scholariq.org/papers/the-moonlighting-enzyme-cd13-old-and-new-functions-to-target/)
- [Losing your nerves? Maybe it's the antibodies](https://scholariq.org/papers/losing-your-nerves-maybe-it-s-the-antibodies/)
- [Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)](https://scholariq.org/papers/report-from-the-fifth-international-consensus-meeting-to-harmonize-core-outcome/)
- [CD13/APN regulates endothelial invasion and filopodia formation](https://scholariq.org/papers/cd13-apn-regulates-endothelial-invasion-and-filopodia-formation/)
- [CD13 is a novel mediator of monocytic/endothelial cell adhesion](https://scholariq.org/papers/cd13-is-a-novel-mediator-of-monocytic-endothelial-cell-adhesion/)
- [Suppression of Glomerulonephritis in Lupus‐Prone NZB × NZW Mice by RN486, a Selective Inhibitor of Bruton's Tyrosine Kinase](https://scholariq.org/papers/suppression-of-glomerulonephritis-in-lupus-prone-nzb-nzw-mice-by-rn486-a/)
- [Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial](https://scholariq.org/papers/clinically-meaningful-responses-to-dupilumab-in-adolescents-with-uncontrolled/)
- [Disease trajectories in childhood atopic dermatitis: an update and practitioner's guide](https://scholariq.org/papers/disease-trajectories-in-childhood-atopic-dermatitis-an-update-and-practitioner-s/)
- [Real-world treatment utilization and economic implications of lupus nephritis disease activity in the United States](https://scholariq.org/papers/real-world-treatment-utilization-and-economic-implications-of-lupus-nephritis/)

## Researcher topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Food Allergy and Anaphylaxis Research](https://scholariq.org/topics/food-allergy-and-anaphylaxis-research/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)

## Researcher university

- [Myovant Sciences (United States)](https://scholariq.org/institutions/myovant-sciences-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.